Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00504062 | Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma | PHASE3 | COMPLETED | 240 | — | — | Oct 1, 2006 | Oct 1, 2007 | Aug 24, 2011 | 1 | Japan |
| NCT00646594 | Atlantis Symbicort | PHASE3 | COMPLETED | 1,200 | — | — | Nov 1, 2003 | Jan 1, 2005 | Mar 27, 2009 | - | — |
| NCT00646620 | Symbicort Onset of Action 1 | PHASE3 | COMPLETED | 48 | — | — | Apr 1, 2003 | Sep 1, 2003 | Apr 6, 2009 | - | — |
| NCT00646009 | Symbicort Onset of Action 2 | PHASE3 | COMPLETED | 48 | — | — | Mar 1, 2003 | Aug 1, 2003 | Jan 24, 2011 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | budesonide/formoterol |
| 2 | ACTIVE_COMPARATOR | fluticasone/salmeterol |
| 3 | ACTIVE_COMPARATOR | albuterol |
| Name | Type | Description |
|---|---|---|
| budesonide | DRUG | - |
| fluticasone | DRUG | - |
| budesonide/formoterol (Symbicort) | DRUG | - |
| fluticasone/salmeterol (Advair) | DRUG | - |
| fluticasone/salmeterol (Advair Diskus) | DRUG | - |
| albuterol (Ventolin) | DRUG | - |
| budesonide/formoterol | DRUG | - |
| fluticasone/salmeterol | DRUG | - |
| albuterol | DRUG | - |
Inclusion Criteria: * Provision of signed written informed consent by patient's legal representative; when possible a signed written informed consent should be obtained from the patient themselves * Patients diagnosed as having bronchial asthma regardless of type of asthma i.e. perennial or seasona...